Transcatheter mitral and tricuspid valve's next frontier — the structural heart disease market's expansion from the commercially mature TAVR segment toward the transcatheter mitral valve repair and replacement (TMVR) and transcatheter tricuspid valve intervention (TTVI) markets — addressing the large prevalence of mitral regurgitation (affecting ten million Americans) and tricuspid...